A clinical perspective of disease tolerance in sepsis

Event Slider

Several seminars are held weekly at the Instituto Gulbenkian de Ciência, an initiative that aims to bring together all researchers around the topics under discussion.

The sessions, with internal researchers or guests, contribute to stimulate the open and extremely collaborative culture of the IGC.

You can read the abstract of this seminar to learn more about it.

 

Sepsis is a life-threatening condition arising from a dysregulated host response to infection. Current therapies rely on pathogen eradication and support of dysregulated organ functions. Adjunctive therapies addressing the failing host response are in their infancy. Two current developments, i.e. i) phenotyping and ii) introducing disease tolerance as a complementary coping mechanism besides resistance contributed to conceptual progress in understanding the syndrome. Emerging clinical evidence - albeit scarce – will be summarized by placing it into the context of evolutionary ecology and stress biology. As a result the talk aims to pinpoint open questions and blind spots regarding the complexity of sepsis and introduces current avenues for translational research.  Moreover, we challenge the notion that disease tolerance and resistance are unconnected,  opposing response patterns. Instead, we propose to view resilience as a collective term that comprises the sum of both defence traits with fundamental implications for the design of clinical sepsis trials.

 


SPEAKER

Michael Bauer
Jena University Hospital, Germany

 

HOST
Miguel Soares

Cookies settings

Cookies Selection

This website uses cookies to improve your browsing experience, security, and its website performance. We may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.